Foster Chen, MD
Orthopaedic Surgery · Seattle, WANPI 1326399080
Payments from drug & device makers
Across 71 payments — averaging $145.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$6K
- Zimmer Biomet$2K
- Summit Surgical Corp.$1K
- Invictus Surgical Incorporated$273
- Smith+Nephew$194
- Conformis, Inc.$168
- plus $446 from 5 others
What the payments were for
- Travel & lodging$4,48643%
- Food & beverage$4,53144%
- Education$1,31013%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 41 | $5,667 |
| Zimmer Biomet | 17 | $2,379 |
| Summit Surgical Corp. | 1 | $1,200 |
| Invictus Surgical Incorporated | 1 | $273 |
| Smith+Nephew | 3 | $194 |
| Conformis, Inc. | 1 | $168 |
| Davol Inc. | 1 | $142 |
| Medical Device Business Services, Inc. | 1 | $108 |
| Medtronic | 1 | $107 |
| Johnson & Johnson(2 entities) | 3 | $78 |
| Illuminoss Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$4,607
- Avenir$1,137
- Persona$473
- INSIGNIA$173
- iTotal Identity PS$168
- GMRS$153
- CFN CHLORAPREP$142
- EVOS$141
- EXETER$137
- Taperloc$110
- Kincise Surgical Automated System$108
- AQUAMANTYS$107
How this compares
$10,327 in reported general payments places this provider in the 70th percentile of 495 orthopaedic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 431 | $4,898 |
| Cefadroxil | 112 | $1,268 |
| Oxycodone Hcl | 134 | $1,256 |
| Amoxicillin | 138 | $815 |
| Ondansetron Hcl | 118 | $721 |
| Pregabalin | 39 | $365 |
| Mupirocin | 24 | $276 |
| Duloxetine Hcl | 21 | $235 |
| Meloxicam | 20 | $132 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Seattle
- James PritchettSeattle$6.4M
- Jeffrey RohSeattle$4.7M
- James CrutcherSeattle$3.5M
- Keith MayoSeattle$3.1M
- Matthew SaltzmanSeattle$1.8M
- Burt YaszaySeattle$1.5M
- Sean ToomeySeattle$1.3M
- Robert HartSeattle$942K
- Daniel SchwartzSeattle$508K
- Michael BrageSeattle$507K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.